Our therapeutic strategy for the petroclival meningioma (PCM) allows for observation for asymptomatic and microsurgery for symptomatic cases. For evaluation of this strategy, functional status assessed by the Karnofsky Performance Score (KPS) in each group was retrospectively analyzed. The records of 29 patients with PCMs were reviewed. Fifteen patients were enrolled in the observation group and the median follow-up period was 40 months (range, 5-170). Eighteen patients underwent operative procedures for resection of PCMs and the median follow-up period was 65.5 months (range, 9-194). In the observation group, 60% of the cases showed radiological tumor growth during the follow-up period. There was functional deterioration in 47% of the cases. The growing tumors were unpredictable. In the microsurgery group, gross tumor resection was accomplished in 22% of the cases. The surgical morbidity rate, a KPS less than 80, at three months after surgery and at the time of the last follow-up was 56% and 6%, respectively. Postoperative KPS at three months after surgery was significantly worse than preoperative KPS. However, most of the patients with a worse KPS had recovered at the time of the last follow-up and they had a favorable functional outcome. Regarding the degree of the KPS change, there was no significant difference between the observation and the microsurgery groups during the follow-up periods. Based on the functional outcomes of each group, our therapeutic strategy for PCMs was shown to be reasonable and warranted.